会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Pharmacologically active amine boranes
    • 药理活性胺硼烷
    • US4368194A
    • 1983-01-11
    • US284279
    • 1981-07-17
    • Bernard F. SpielvogelAndrew T. McPhailIris H. Hall
    • Bernard F. SpielvogelAndrew T. McPhailIris H. Hall
    • C07F5/00C07F5/02
    • C07F5/006C07F5/027
    • The use of a mine boranes to inhibit the inflammation process is disclosed.hese boranes, which are boron analogs of .alpha.-amino acids, effectively block the following: general inflammation, induced arthritis, and the writhing reflex associated with inflammation pain. The inflammation associated with pleurisy is also inhibited. The boron analogs are shown in vitro to inhibit the release of lysosomal enzymes from liver and polymorphonuclear neutrophils (PMNs). Further, prostaglandin synthesis is blocked by these compounds at a low concentration, viz., 10.sup.-6 M.Liver oxidative phosphorylation processes are also uncoupled by these compounds, but PMN migration is unaltered at 10.sup.-4 M. The elevation of cyclic adenosine monophosphate in PMNs correlates positively with in vivo antiarthritic activity. Studies in rodents demonstrate that these boron analogs may be used at safe therapeutic doses. Several compounds per se are included within the scope of the invention.
    • 公开了使用矿物硼烷抑制炎症过程。 这些硼烷是α-氨基酸的硼类似物,有效地阻断了以下:一般炎症,诱发的关节炎和与炎症疼痛相关的扭动反射。 与胸膜炎相关的炎症也受到抑制。 硼类似物在体外显示以抑制溶酶体酶从肝脏和多形核嗜中性粒细胞(PMN)的释放。 此外,前列腺素合成被这些化合物以低浓度,即10-6M阻断。肝氧化磷酸化过程也被这些化合物解偶联,但是PMN迁移在10-4M不变。环磷酸腺苷的升高 PMNs与体内抗关节炎活性呈正相关。 啮齿类动物的研究表明,这些硼类似物可以以安全的治疗剂量使用。 本发明的范围包括几种化合物本身。
    • 6. 发明授权
    • Binuclear copper (II) carboxylates formed from amine-carboxyboranes
    • 由胺 - 羧基硼烷形成的双核铜(II)羧酸盐
    • US4550186A
    • 1985-10-29
    • US512729
    • 1983-07-11
    • Andrew T. McPhailBernard F. SpielvogelIris H. Hall
    • Andrew T. McPhailBernard F. SpielvogelIris H. Hall
    • C07F5/02C07F1/08
    • C07F5/027
    • A compound of the formula[Cu(R.sub.3 NBH.sub.2 CO.sub.2).sub.2. R.sub.3 NBH.sub.2 CO.sub.2 H].sub.2wherein each R independently represents H, C.sub.1 -C.sub.10 alkyl, or phenyl and L represents a non-toxic Lewis base capable of forming a coordinate bond with the copper with the provisos that any two or three R attached to the same nitrogen may represent a C.sub.4 -C.sub.5 alkylene group containing up to 2 non-cumulative double bonds optionally having 1 or 2 carbons replaced by oxygen or nitrogen, that any 3 R attached to the same nitrogen when taken together with the nitrogen may represent a 6-membered aromatic ring containing 1, 2 or 3 nitrogen atoms, and that any R containing a carbon atom may be substituted with a hydroxyl, ether, ester, carboxyl, or amino functional group is disclosed along with methods of making these compounds and methods of using these compounds as antihyperlipidemic agents and antineoplastic agents.
    • 式[Cu(R 3 NBH 2 CO 2)2)的化合物。 R3NBH2CO2H] 2,其中每个R独立地表示H,C1-C10烷基或苯基,L表示能够与铜形成配位键的无毒路易斯碱,条件是连接到相同氮的任何两个或三个R可以 表示含有至多2个非累积双键的C4-C5亚烷基,任选具有1或2个碳被氧或氮取代,当与氮一起连接到相同氮时的任何3R可以表示6元芳族 含有1,2或3个氮原子的环,并且含有碳原子的任何R可以被羟基,醚,酯,羧基或氨基官能团取代,以及制备这些化合物的方法和使用这些化合物的方法 作为抗高脂血症药和抗肿瘤药。
    • 7. 发明授权
    • Pharmacologically active amine boranes
    • 药理活性胺硼烷
    • US4312989A
    • 1982-01-26
    • US68356
    • 1979-08-21
    • Bernard F. SpielvogelAndrew T. McPhailIris H. Hall
    • Bernard F. SpielvogelAndrew T. McPhailIris H. Hall
    • C07F5/00C07F5/02A61K31/69
    • C07F5/006C07F5/027
    • The use of amine boranes to inhibit the inflammation process is disclosed. These boranes, which are boron analogs of .alpha.-amino acids, effectively block the following: general inflammation, induced arthritis, and the writhing reflex associated with inflammation pain. The inflammation associated with pleurisy is also inhibited. The boron analogs are shown in vitro to inhibit the release of lysosomal enzymes from liver and polymorphonuclear neutrophils (PMNs). Further, prostaglandin synthesis is blocked by these compounds at a low concentration, viz, 10.sup.-6 M.Liver oxidative phosphorylation processes are also uncoupled by these compounds, but PMN migration is unaltered at 10.sup.-4 M. The elevation of cyclic adenosine monophosphate in PMNs correlates positively with in vivo antiarthritic activity. Studies in rodents demonstrate that these boron analogs may be used at safe therapeutic doses. Several compounds per se are included within the scope of the invention.
    • 公开了使用胺硼烷来抑制炎症过程。 这些硼烷是α-氨基酸的硼类似物,有效地阻断了以下:一般炎症,诱发的关节炎和与炎症疼痛相关的扭动反射。 与胸膜炎相关的炎症也受到抑制。 硼类似物在体外显示以抑制溶酶体酶从肝脏和多形核嗜中性粒细胞(PMN)的释放。 此外,前列腺素合成被这些化合物以低浓度(即10-6M)阻断。 肝氧化磷酸化过程也被这些化合物解偶联,但PMN迁移在10-4M不变。 PMN中环磷酸腺苷的升高与体内抗关节炎活性呈正相关。 啮齿动物的研究表明,这些硼类似物可以以安全的治疗剂量使用。 本发明的范围包括几种化合物本身。